UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 8.886

Sortiert nach

Mutation incidence and coincidence in non small-cell lung cancer: meta-analyses by ethnicity and histology (mutMap)

Annals of oncology, 2013-09, Vol.24 (9), p.2371-2376

2013

Link zum Volltext

Verfügbarkeit prüfen

Pan-Asian adapted Clinical Practice Guidelines for the management of patients with metastatic non-small-cell lung cancer: a CSCO–ESMO initiative endorsed by JSMO, KSMO, MOS, SSO and TOS

Annals of oncology, 2019-02, Vol.30 (2), p.171-210

2019

Link zum Volltext

Verfügbarkeit prüfen

Osimertinib or Platinum–Pemetrexed in EGFR T790M–Positive Lung Cancer

The New England journal of medicine, 2017-02, Vol.376 (7), p.629-640

2017

Link zum Volltext

Verfügbarkeit prüfen

An Analysis of the Binding Function and Structural Organization of the Protein Corona

Journal of the American Chemical Society, 2020-05, Vol.142 (19), p.8827-8836

2020

Link zum Volltext

Verfügbarkeit prüfen

First-line erlotinib versus gemcitabine/cisplatin in patients with advanced EGFR mutation-positive non-small-cell lung cancer: analyses from the phase III, randomized, open-label, ENSURE study

Annals of oncology, 2015-09, Vol.26 (9), p.1883-1889

2015

Link zum Volltext

Verfügbarkeit prüfen

Erlotinib as second-line treatment in patients with advanced non-small-cell lung cancer and asymptomatic brain metastases: a phase II study (CTONG–0803)

Annals of oncology, 2013-04, Vol.24 (4), p.993-999

2013

Link zum Volltext

Verfügbarkeit prüfen

Nanocavity optomechanical torque magnetometry and radiofrequency susceptometry

Nature nanotechnology, 2017-02, Vol.12 (2), p.127-131

2017

Link zum Volltext

Verfügbarkeit prüfen

Effect of dose adjustment on the safety and efficacy of afatinib for EGFR mutation-positive lung adenocarcinoma: post hoc analyses of the randomized LUX-Lung 3 and 6 trials

Annals of oncology, 2016-11, Vol.27 (11), p.2103-2110

2016

Link zum Volltext

Verfügbarkeit prüfen

Osimertinib versus platinum–pemetrexed for patients with EGFR T790M advanced NSCLC and progression on a prior EGFR-tyrosine kinase inhibitor: AURA3 overall survival analysis

Annals of oncology, 2020-11, Vol.31 (11), p.1536-1544

2020

Link zum Volltext

Verfügbarkeit prüfen

Associations of tissue tumor mutational burden and mutational status with clinical outcomes in KEYNOTE-042: pembrolizumab versus chemotherapy for advanced PD-L1-positive NSCLC

Annals of oncology, 2023-04, Vol.34 (4), p.377-388

2023

Link zum Volltext

Verfügbarkeit prüfen

Exotic spin-dependent interactions through unparticle exchange

The journal of high energy physics, 2024-01, Vol.2024 (1), p.83-21, Article 83

2024

Link zum Volltext

Verfügbarkeit prüfen

Spatial and Resource Factors Influencing High Microbial Diversity in Soil

Applied and Environmental Microbiology, 2002-01, Vol.68 (1), p.326-334

2002

Link zum Volltext

Verfügbarkeit prüfen

Survival benefit with erlotinib maintenance therapy in patients with advanced non-small-cell lung cancer (NSCLC) according to response to first-line chemotherapy

Annals of oncology, 2012-02, Vol.23 (2), p.388-394

2012

Link zum Volltext

Verfügbarkeit prüfen

Histone deacetylase inhibitor treatment restores memory‐related gene expression and learning ability in neonicotinoid‐treated Apis mellifera

Insect molecular biology, 2018-08, Vol.27 (4), p.512-521

2018

Link zum Volltext

Verfügbarkeit prüfen

New Limits on Exotic Spin-Dependent Interactions at Astronomical Distances

Physical review letters, 2023-09, Vol.131 (9), p.091002-091002, Article 091002

2023

Link zum Volltext

Verfügbarkeit prüfen

Correlation of extent of ALK FISH positivity and crizotinib efficacy in three prospective studies of ALK-positive patients with non-small-cell lung cancer

Annals of oncology, 2018-09, Vol.29 (9), p.1964-1971

2018

Link zum Volltext

Verfügbarkeit prüfen

Inflammatory pathways linking obesity and ovarian dysfunction

Journal of reproductive immunology, 2011-03, Vol.88 (2), p.142-148

2011

Link zum Volltext

Verfügbarkeit prüfen

Fast Assembly of Ordered Block Copolymer Nanostructures through Microwave Annealing

ACS nano, 2010-11, Vol.4 (11), p.7021-7029

2010

Link zum Volltext

Verfügbarkeit prüfen

DIFFRACTION-LIMITED VISIBLE LIGHT IMAGES OF ORION TRAPEZIUM CLUSTER WITH THE MAGELLAN ADAPTIVE SECONDARY ADAPTIVE OPTICS SYSTEM (MagAO)

The Astrophysical journal, 2013-09, Vol.774 (2), p.1-13

2013

Link zum Volltext

Verfügbarkeit prüfen

Toward the prevention of coronavirus infection: what role can polymers play?

Materials today advances, 2021-06, Vol.10, p.100140-100140, Article 100140

2021

Link zum Volltext

Verfügbarkeit prüfen

Pemetrexed versus gefitinib as a second-line treatment in advanced nonsquamous nonsmall-cell lung cancer patients harboring wild-type EGFR (CTONG0806): a multicenter randomized trial

Annals of oncology, 2014-12, Vol.25 (12), p.2385-2391

2014

Link zum Volltext

Verfügbarkeit prüfen

Elimination Pathways of Nanoparticles

ACS nano, 2019-05, Vol.13 (5), p.5785-5798

2019

Link zum Volltext

Verfügbarkeit prüfen

The entry of nanoparticles into solid tumours

Nature materials, 2020-05, Vol.19 (5), p.566-575

2020

Link zum Volltext

Verfügbarkeit prüfen

Chip implementation of a new hyperchaotic oscillator

Electronics letters, 2017-02, Vol.53 (4), p.226-228

2017

Link zum Volltext

Verfügbarkeit prüfen

Quality of life (QoL) analyses from OPTIMAL (CTONG-0802), a phase III, randomised, open-label study of first-line erlotinib versus chemotherapy in patients with advanced EGFR mutation-positive non-small-cell lung cancer (NSCLC)

Annals of oncology, 2013-06, Vol.24 (6), p.1615-1622

2013

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 8.886

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(7.610)
Mit Volltextzugriff
(8.003)

Publikationsform

3 weitere anzeigen...

Weniger anzeigen...

Sprache

8 weitere anzeigen...

Weniger anzeigen...

Erscheinungsjahr

n.n

Thema

Science & Technology
(6.532)
Life Sciences & Biomedicine
(3.165)
Physical Sciences
(2.452)
Technology
(2.019)
Humans
(2.006)
Physics
(1.514)
Biological And Medical Sciences
(1.405)
Exact Sciences And Technology
(1.399)
Male
(1.292)
Female
(1.251)
Animals
(1.081)
Medical Sciences
(990)
Materials Science
(928)
Engineering
(891)
Chemistry
(880)
Applied Sciences
(751)
Middle Aged
(743)
Adult
(727)
Materials Science, Multidisciplinary
(725)
Physics, Applied
(679)

15 weitere anzeigen...

Weniger anzeigen...

Kollektion

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

Menü

Weitere Dienste

Einstellungen

Mutation incidence and coincidence in non small-cell lung cancer: meta-analyses by ethnicity and histology (mutMap)

Pan-Asian adapted Clinical Practice Guidelines for the management of patients with metastatic non-small-cell lung cancer: a CSCO–ESMO initiative endorsed by JSMO, KSMO, MOS, SSO and TOS

Osimertinib or Platinum–Pemetrexed in EGFR T790M–Positive Lung Cancer

An Analysis of the Binding Function and Structural Organization of the Protein Corona

First-line erlotinib versus gemcitabine/cisplatin in patients with advanced EGFR mutation-positive non-small-cell lung cancer: analyses from the phase III, randomized, open-label, ENSURE study

Erlotinib as second-line treatment in patients with advanced non-small-cell lung cancer and asymptomatic brain metastases: a phase II study (CTONG–0803)

Nanocavity optomechanical torque magnetometry and radiofrequency susceptometry

Effect of dose adjustment on the safety and efficacy of afatinib for EGFR mutation-positive lung adenocarcinoma: post hoc analyses of the randomized LUX-Lung 3 and 6 trials

Osimertinib versus platinum–pemetrexed for patients with EGFR T790M advanced NSCLC and progression on a prior EGFR-tyrosine kinase inhibitor: AURA3 overall survival analysis

Associations of tissue tumor mutational burden and mutational status with clinical outcomes in KEYNOTE-042: pembrolizumab versus chemotherapy for advanced PD-L1-positive NSCLC

Exotic spin-dependent interactions through unparticle exchange

Spatial and Resource Factors Influencing High Microbial Diversity in Soil

Survival benefit with erlotinib maintenance therapy in patients with advanced non-small-cell lung cancer (NSCLC) according to response to first-line chemotherapy

Histone deacetylase inhibitor treatment restores memory‐related gene expression and learning ability in neonicotinoid‐treated Apis mellifera

New Limits on Exotic Spin-Dependent Interactions at Astronomical Distances

Correlation of extent of ALK FISH positivity and crizotinib efficacy in three prospective studies of ALK-positive patients with non-small-cell lung cancer

Inflammatory pathways linking obesity and ovarian dysfunction

Fast Assembly of Ordered Block Copolymer Nanostructures through Microwave Annealing

DIFFRACTION-LIMITED VISIBLE LIGHT IMAGES OF ORION TRAPEZIUM CLUSTER WITH THE MAGELLAN ADAPTIVE SECONDARY ADAPTIVE OPTICS SYSTEM (MagAO)

Toward the prevention of coronavirus infection: what role can polymers play?

Pemetrexed versus gefitinib as a second-line treatment in advanced nonsquamous nonsmall-cell lung cancer patients harboring wild-type EGFR (CTONG0806): a multicenter randomized trial

Elimination Pathways of Nanoparticles

The entry of nanoparticles into solid tumours

Chip implementation of a new hyperchaotic oscillator

Quality of life (QoL) analyses from OPTIMAL (CTONG-0802), a phase III, randomised, open-label study of first-line erlotinib versus chemotherapy in patients with advanced EGFR mutation-positive non-small-cell lung cancer (NSCLC)

Suchergebnisse filtern